ClinicalTrials.Veeva

Menu

Airway Inflammation and Remodeling in Asthma and COPD.

M

Medical University of Warsaw

Status

Completed

Conditions

Asthma
COPD

Study type

Observational

Funder types

Other

Identifiers

NCT02069054
IPU-DIMPA-WUM13(2)

Details and patient eligibility

About

Asthma and chronic obstructive pulmonary disease (COPD) are inflammatory airway diseases. Although the clinical features of asthma and COPD may be similar, the pathogenesis of these diseases differs in many aspects.

The aim of this study is:

  • to evaluate airway inflammation in asthma and COPD,
  • to evaluate airway remodeling in asthma and COPD as compared to healthy subjects,
  • to assess the relationship between markers of airway inflammation and airway remodeling in asthma and COPD patients.

Material and methods:

  • mild to moderate asthma patients diagnosed in accordance with Global Initiative for Asthma (GINA) guidelines,
  • mild to moderate COPD patients diagnosed in accordance with Global initiative for chronic Obstructive Lung Disease (GOLD) guidelines,
  • healthy subjects as controls.

Airway inflammation is assessed in induced sputum (IS), exhaled breath condensate (EBC), bronchoalveolar lavage fluid (BALF) and specimens from endobronchial forceps biopsy. Airway wall thickness is evaluated in high resolution computed tomography (HRCT), endobronchial ultrasound (EBUS) and basement membrane thickness (BMT) in biopsy specimens.

We plan to compare airway inflammation and features of airway remodeling in asthma and COPD patients.

Enrollment

72 patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • a clinical diagnosis of asthma or COPD in accordance with GINA or GOLD, respectively
  • control group - healthy volunteers without any history of lung disease

Exclusion criteria

  • age below 18 years
  • exacerbation in the past 6 weeks
  • inhaled corticosteroid therapy at least 6 weeks prior to study enrollment
  • significant co-morbidities

Trial design

72 participants in 3 patient groups

Asthma
Description:
Patients with mild to moderate asthma diagnosed in accordance with GINA
COPD
Description:
Patients with mild to moderate COPD diagnosed in accordance with GOLD
Control
Description:
Healthy subjects

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems